Abstract
Biobanking in healthcare has evolved over the last few decades from simple biological sample repositories to complex and dynamic units with multi-organisational infrastructure networks and has become an essential tool for modern medical research. Cardiovascular tissue biobanking provides a unique opportunity to utilise cardiac and vascular samples for translational research into heart failure and other related pathologies. Current techniques for diagnosis, classification, and treatment monitoring of cardiac disease primarily rely on interpretation of clinical signs, imaging, and blood biomarkers. Further research at the disease source (i.e., myocardium and blood vessels) has been limited by a relative lack of access to quality human cardiac tissue and the inherent shortcomings of most animal models of heart disease.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call